<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <!-- common.css -->
  <style>* {-webkit-tap-highlight-color: rgba(0,0,0,0);}html {-webkit-text-size-adjust: none;}body {font-family: Arial, Helvetica, sans-serif;margin: 0;color: #333;word-wrap: break-word;}h1, h2, h3, h4, h5, h6 {line-height: 1.1;}img {max-width: 100% !important;}blockquote {margin: 0;padding: 0 15px;color: #777;border-left: 4px solid #ddd;}hr {background-color: #ddd;border: 0;height: 1px;margin: 15px 0;}code {font-family: Menlo, Consolas, 'Ubuntu Mono', Monaco, 'source-code-pro', monospace;line-height: 1.4;margin: 0;padding: 0.2em 0;font-size: 85%;background-color: rgba(0,0,0,0.04);border-radius: 3px;}pre {margin: 0;}pre > code {margin: 0;padding: 0;font-size: 100%;word-break: normal;background: transparent;border: 0;}ol {list-style-type: decimal;}ol ol, ul ol {list-style-type: lower-latin;}ol ol ol, ul ol ol, ul ul ol, ol ul ol {list-style-type: lower-roman;}table {border-spacing: 0;border-collapse: collapse;margin-top: 0;margin-bottom: 16px;}table th {font-weight: bold;}table th, table td {padding: 6px 13px;border: 1px solid #ddd;}table tr {border-top: 1px solid #ccc;}table tr:nth-child(even) {background-color: #f8f8f8;}input[type="checkbox"] {cursor: default;margin-right: 0.5em;font-size: 13px;}.task-list-item {list-style-type: none;}.task-list-item+.task-list-item {margin-top: 3px;}.task-list-item input {float: left;margin: 0.3em 1em 0.25em -1.6em;vertical-align: middle;}#tag-field {margin: 8px 2px 10px;}#tag-field .tag {display: inline-block;background: #cadff3;border-radius: 4px;padding: 1px 8px;color: black;font-size: 12px;margin-right: 10px;line-height: 1.4;}</style>
  <!-- ace-static.css -->
  <style>.ace_static_highlight {white-space: pre-wrap;}.ace_static_highlight .ace_gutter {width: 2em;text-align: right;padding: 0 3px 0 0;margin-right: 3px;}.ace_static_highlight.ace_show_gutter .ace_line {padding-left: 2.6em;}.ace_static_highlight .ace_line {position: relative;}.ace_static_highlight .ace_gutter-cell {-moz-user-select: -moz-none;-khtml-user-select: none;-webkit-user-select: none;user-select: none;top: 0;bottom: 0;left: 0;position: absolute;}.ace_static_highlight .ace_gutter-cell:before {content: counter(ace_line, decimal);counter-increment: ace_line;}.ace_static_highlight {counter-reset: ace_line;}</style>
  <style>.ace-chrome .ace_gutter {background: #ebebeb;color: #333;overflow : hidden;}.ace-chrome .ace_print-margin {width: 1px;background: #e8e8e8;}.ace-chrome {background-color: #FFFFFF;color: black;}.ace-chrome .ace_cursor {color: black;}.ace-chrome .ace_invisible {color: rgb(191, 191, 191);}.ace-chrome .ace_constant.ace_buildin {color: rgb(88, 72, 246);}.ace-chrome .ace_constant.ace_language {color: rgb(88, 92, 246);}.ace-chrome .ace_constant.ace_library {color: rgb(6, 150, 14);}.ace-chrome .ace_invalid {background-color: rgb(153, 0, 0);color: white;}.ace-chrome .ace_fold {}.ace-chrome .ace_support.ace_function {color: rgb(60, 76, 114);}.ace-chrome .ace_support.ace_constant {color: rgb(6, 150, 14);}.ace-chrome .ace_support.ace_type,.ace-chrome .ace_support.ace_class.ace-chrome .ace_support.ace_other {color: rgb(109, 121, 222);}.ace-chrome .ace_variable.ace_parameter {font-style:italic;color:#FD971F;}.ace-chrome .ace_keyword.ace_operator {color: rgb(104, 118, 135);}.ace-chrome .ace_comment {color: #236e24;}.ace-chrome .ace_comment.ace_doc {color: #236e24;}.ace-chrome .ace_comment.ace_doc.ace_tag {color: #236e24;}.ace-chrome .ace_constant.ace_numeric {color: rgb(0, 0, 205);}.ace-chrome .ace_variable {color: rgb(49, 132, 149);}.ace-chrome .ace_xml-pe {color: rgb(104, 104, 91);}.ace-chrome .ace_entity.ace_name.ace_function {color: #0000A2;}.ace-chrome .ace_heading {color: rgb(12, 7, 255);}.ace-chrome .ace_list {color:rgb(185, 6, 144);}.ace-chrome .ace_marker-layer .ace_selection {background: rgb(181, 213, 255);}.ace-chrome .ace_marker-layer .ace_step {background: rgb(252, 255, 0);}.ace-chrome .ace_marker-layer .ace_stack {background: rgb(164, 229, 101);}.ace-chrome .ace_marker-layer .ace_bracket {margin: -1px 0 0 -1px;border: 1px solid rgb(192, 192, 192);}.ace-chrome .ace_marker-layer .ace_active-line {background: rgba(0, 0, 0, 0.07);}.ace-chrome .ace_gutter-active-line {background-color : #dcdcdc;}.ace-chrome .ace_marker-layer .ace_selected-word {background: rgb(250, 250, 255);border: 1px solid rgb(200, 200, 250);}.ace-chrome .ace_storage,.ace-chrome .ace_keyword,.ace-chrome .ace_meta.ace_tag {color: rgb(147, 15, 128);}.ace-chrome .ace_string.ace_regex {color: rgb(255, 0, 0)}.ace-chrome .ace_string {color: #1A1AA6;}.ace-chrome .ace_entity.ace_other.ace_attribute-name {color: #994409;}.ace-chrome .ace_indent-guide {background: url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAACCAYAAACZgbYnAAAAE0lEQVQImWP4////f4bLly//BwAmVgd1/w11/gAAAABJRU5ErkJggg==") right repeat-y;}</style>
  <!-- export.css -->
  <style>
    body{margin:0 auto;max-width:800px;line-height:1.4}
    #nav{margin:5px 0 10px;font-size:15px}
    #titlearea{border-bottom:1px solid #ccc;font-size:17px;padding:10px 0;}
    #contentarea{font-size:15px;margin:16px 0}
    .cell{outline:0;min-height:20px;margin:5px 0;padding:5px 0;}
    .code-cell{font-family:Menlo,Consolas,'Ubuntu Mono',Monaco,'source-code-pro',monospace;font-size:12px;}
    .latex-cell{white-space:pre-wrap;}
  </style>
  <!-- User CSS -->
  <style> .text-cell {font-size: 15px;}.code-cell {font-size: 12px;}.markdown-cell {font-size: 15px;}.latex-cell {font-size: 15px;}</style>
</head>
<body>
  <div id="nav"><div>Previous: <a href='Viruses - EBV, CMV, Parvovirus B19.html'>Viruses - EBV, CMV, Parvovirus B19</a>, Up: <a href='index.html'>Index</a></div></div>
  <div id="titlearea">
    <h2>Stem Cells, Hematopoiesis, Marrow Failure</h2>
  </div>
  <div id="contentarea"><div class="cell markdown-cell"><h1 id="hematopoeisis">Hematopoeisis</h1>
<p>Hemopoeisis includes erythropoeisis (RBC formation), leukopoiesis (formation of granulocytes and monocytes), and thrombopoeisis. <strong>Occurs in the Bone Marrow</strong>.</p>
<ul>
<li>Erythroids =&gt; RBCs</li><li>Myeloids =&gt; Thrombocytes, Granulocytes, and Monocytes</li><li><strong>Myeloid:Erythroid Ratio = 3:1</strong></li></ul>
<p>All blood cells originate from <strong>Hematopoetic Stem Cells</strong></p>
<ul>
<li><strong>CD34 positive</strong>, which can be used for cell sorting for transplantation</li></ul>
</div><div class="cell text-cell"><img src="resources/79C65738C46765647DA4B792070EB878.png" alt="Screen Shot 2016-02-07 at 10.36.51 AM.png"></div><div class="cell markdown-cell"><h4 id="hematopoesis-in-utero-">Hematopoesis in utero:</h4>
</div><div class="cell text-cell"><img src="resources/99E81B2AA22044E672B5E15A812A7AD1.png" alt="Screen Shot 2016-02-07 at 10.40.12 AM.png"></div><div class="cell markdown-cell"><h2 id="hierarchy-of-progenitor-cells-">Hierarchy of Progenitor Cells:</h2>
<ul>
<li>Hematopoeitic Stem Cell<ul>
<li><strong>Common myeloid progenitor</strong><ul>
<li>Granulocyte / Macrophage Progenitor (stimulated by <strong>GM-CSF</strong>)<ul>
<li>Dendritic Cells</li><li>Granulocytes (PMNs, Basophils, Eosinophils) (stimulated by G-CSF)</li><li>Monocytes (stimulated by M-CSF)</li></ul>
</li><li>Megakaryocyte / Erythrocyte Progenitor<ul>
<li>RBCs (stimulated by <strong>EPO</strong>)</li><li>Plateletes (stimulated by <strong>TPO</strong>)</li></ul>
</li></ul>
</li><li>Common lymphoid progenitor<ul>
<li>Dendritic Cells</li><li>T cells (thymosin signaling in thymus)</li><li>B cells (develop in bone marrow under IL-7 signaling)</li><li>NK cells</li></ul>
</li></ul>
</li></ul>
<h2 id="erythropoiesis">Erythropoiesis</h2>
</div><div class="cell text-cell"><img src="resources/6C44995F142AC45BB1978188127E6A02.png" alt="Screen Shot 2016-02-07 at 10.44.50 AM.png"></div><div class="cell markdown-cell"><ul>
<li>Way to think about changes:<ul>
<li><strong>Proerythroblast</strong> = making the RNA for future protein synthesis, thus nucleoli present</li><li><strong>Basophilic erythroblast</strong> = RNA is done (nucleoli are gone) and is being used for protein synthesis (basophilic cytoplasm)</li><li><strong>Orthochromic erythroblast</strong> = protein synthesis is done (no basophilia), and nucleus is shrinking to soon disappear<ul>
<li>Note that this may be present in circulation as a nucleated RBC in abnormal circumstances (hemolytic anemias like hereditary spherocytosis, WAIHA)</li></ul>
</li><li>Reticulocyte = larger, some ribosomes still left</li></ul>
</li><li>Only RBCs and Reticulocytes found in peripheral blood normally (retic count ~ 1% of RBC number)</li><li><strong>Erythropoeisis is under negative feedback from oxygen delivery to renal tubular cells, which secrete EPO in response to low oxygen sensing</strong></li></ul>
<h2 id="granulopoeisis">Granulopoeisis</h2>
</div><div class="cell text-cell"><img src="resources/E9541F85CE2AAF41373A3221D22BE9A1.png" alt="Screen Shot 2016-02-07 at 10.58.13 AM.png"></div><div class="cell markdown-cell"><ul>
<li>Bands (immature PMNs) are present in the peripheral circulation</li><li>Seperation between PMN, eosinophil, and basophil development occurs at the myelocyte stage</li></ul>
<h2 id="thrombopoeisis">Thrombopoeisis</h2>
<p>Platelets break off from <strong>Megakaryocytes</strong> that are near sinusoids in the bone marrow, which connect to the bloodstream</p>
<ul>
<li>Megakaryoctyes reside in endothelial cell wall</li><li>Regulation of Platelet release by TPO:<ul>
<li>The liver releases <strong>TPO</strong>, which binds to TPO-receptors on both circulating platelets and megakaryocytes</li><li>Decreased platelets in the blood =&gt; less binding of TPO to platelets =&gt; <strong>more binding of TPO to megakaryocytes =&gt; stimulation of thrombopoeisis</strong></li></ul>
</li></ul>
<hr>
<h1 id="bone-marrow-biopsies-and-bone-marrow-failure">Bone Marrow Biopsies and Bone Marrow Failure</h1>
<p>Bone marrow biopsies are assessed for:</p>
<ul>
<li>Cellularity</li><li>Normality of cell production (can be disturbed by megaloblastic changes in folate or B12 deficiency)<ul>
<li>Megaloblastic change = delayed nuclear maturation relative to the cytoplasm, Howell-Jolly bodies</li></ul>
</li><li>M:E ratio (normally 3:1)</li><li>Abnormal cells (leukemias, multiple myelomas, metastatic disease)</li></ul>
<h3 id="bone-marrow-failure">Bone Marrow Failure</h3>
<p>A failure in the production of RBCs, WBCs, Platelets =&gt; <strong>Pancytopenia</strong><br>Causes:</p>
<ul>
<li>Aplastic anemia<ul>
<li>Idiosyncratic and <strong>rare reaction to chloramphenicol</strong> (this is why it's not used unless life-threatening infection)</li><li><strong>Fifth disease from parvovirus B19 =&gt; aplastic anemia in utero</strong> (but not common)</li><li><strong>Myelophthisic Anemia</strong> - crowding out of bone marrow due to infiltration of tumor, granuloma, histocytes, fibrosis</li></ul>
</li><li>Inherited disorders<ul>
<li>Fanconi anemia</li><li>Dyskeratosis congenita</li><li>Schwachman-Diamond syndrome</li></ul>
</li></ul>
</div></div>
  <script>document.body.onkeyup = function(e) {
if (e.keyCode === 37) window.location.href = 'Viruses - EBV, CMV, Parvovirus B19.html';
}</script>
</body>
</html>